Peripheral Artery Disease (PAD) is a medical condition in which plaque builds up on the artery walls, blocking the flow of oxygen-rich blood to the legs, stomach, and arms. Major factors causing PAD are smoking, diabetes, high blood pressure, abnormal cholesterol levels, advancing age and a personal history of vascular disease. The earliest symptom of Peripheral Artery Disease is a cramp-like muscular discomfort called intermittent claudication, while numbness, tingling, weakness or fatigue is also experienced. Patients with severe PAD often develop ulcers in their legs and feet. Its prevention involves a lifelong program involving certain lifestyle changes like healthy eating and physical exercise.

Medical Diagnosis of PAD includes methods like Ankle-Brachial Index, Ultrasound, Angiography, Catheter Angiography and Blood Tests. There are a number of treatment options for the disease that can be used alone or mixed with other devices. They are Percutaneous Trans Luminal Angioplasty (PTA), Drug-Coated Balloons, Stents, Drug-Eluting Stents, Arterial Bypass and Atherectomy.

The global peripheral artery disease market, bolstered by rising healthcare expenditures has seen a persistent growth in the last few years. The report provides an overview of the entire global peripheral artery disease market including the devices market and the atherectomy market. Certain key trends like increased used of DCBs and favorable reimbursements have also been discussed. Growth drivers including rising ageing population, obesity and healthcare expenditures find mention in the report along with the challenges and limitations including underpenetrated treatment market for PAD.

Competition in the global peripheral artery disease market is rather fragmented with big companies recording excellent profits while smaller companies continue to gain prevalence through research and innovation.

The report has forecasted future trend in the global Peripheral Artery Disease market by combining SPSS Inc.’s data integration and analysis capabilities. Regression models have been created by employing various significant variables that have an impact on the market. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests. 

1. Market Overview

1.1 Introduction
1.2 Causes of Peripheral Artery Disease
1.3 Prevention
1.4 Diagnosis
1.4.1 Symptoms
1.4.2 Medical Diagnosis
1.5 Treatment Options for Peripheral Artery Disease
1.5.1 Percutaneous Trans Luminal Angioplasty (PTA)
1.5.2 Drug-Coated Balloons (DCBs)
1.5.3 Stents
1.5.4 Drug-Eluting Stents (DES)
1.5.5 Arterial Bypass
1.5.6 Atherectomy

2. Global Peripheral Artery Disease Market

2.1 Global Peripheral Artery Disease Market by Value
2.2 Global Peripheral Artery Disease Prevalence
2.3 Global Peripheral Artery Devices Market
2.3.1 Peripheral Artery Devices Market by Treatment
2.3.2 Drug Eluting Stents Market by Volume
2.3.3 Drug Eluting Stents Market by Geography

3. Regional Peripheral Artery Disease Market

3.1 The U.S.
3.1.1 The U.S. PAD Diagnosed Cases
3.1.2 The U.S. PAD Interventions and Penetration
3.1.3 The U.S. DCB Procedures and Penetration
3.1.4 The U.S. DCB Market by Value
3.1.5 The U.S. Stents/PTA Procedures and Penetration
3.2 The European Union
3.2.1 The EU PAD Diagnosed cases
3.2.2 The EU PAD Intervention and Penetration

4. Peripheral Atherectomy Market

4.1 Global Peripheral Atherectomy Market
4.2 Regional Peripheral Atherectomy Market
4.2.1 The U.S. Peripheral Atherectomy Market by Value
4.2.2 The European Union Peripheral Atherectomy Market by Value

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Ageing Population
5.1.2 Rising Proportion of Health Expenditure in Emerging Economies
5.1.3 Increasing Obese Population
5.1.4 Rise of Drug-Coated Balloons in the US
5.1.5 Escalating Healthcare Spending

5.2 Trends

5.2.1 DCBs Spur Growth of Atherectomy Market
5.2.2 DCB the Preferred Treatment for ISR
5.2.3 Favorable Atherectomy Reimbursements

5.3 Challenges

5.3.1 PAD market is underpenetrated
5.3.2 PAD Devices to be Hurt by DCBs
5.3.3 Limitation of Peripheral Interventions

6. Competitive Landscape

6.1 Global Peripheral Artery Disease Market by Company
6.2 Global Peripheral Atherectomy Market by Company
6.3 The US Peripheral Atherectomy Market Share

7. Company Profiles

7.1 Cardiovascular Systems Inc.

7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies

7.2 Medtronic Plc.

7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies

7.3 Spectranetics Corp.

7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies

7.4 Boston Scientific Corp.

7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

8. Market Outlook

8.1 Global Peripheral Artery Disease Market Forecast
8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
8.2.3 Regression Analysis  

List of Charts

Types of Atherosclerosis Diseases
Global Peripheral Artery Disease Market by Value (2008-2015E)
Global Peripheral Artery Disease Prevalence by Region (2015)
Treatment Mix for Peripheral Intervention Cases (2015)
Global Drug-Eluting Stents Market by Volume (2008-2015E)
Global Drug-Eluting Stents Volume by Geography (2008-14)
Diagnosed PAD Cases in the U.S. (2012-2015E)
PAD Interventions in the U.S (2012-2015E)
The US Interventional Treatment Methods by Market Share (2015)
DCB Procedures and Penetration Rate in the U.S. (2014-2015E)
The U.S. DCB Market by Value (2014-2018E)
Stents/PTA Procedures and Penetration Rate in the U.S. (2014-2015E)
Diagnosed PAD Cases in the EU (2012-2015E)
PAD Interventions in the EU (2012-2015E)
Global Peripheral Atherectomy Market (2012-2015E)
Total Peripheral Atherectomy Market in the U.S. (2012-2015E)
Total EU Peripheral Atherectomy Market (2012-2015E)
Global Population Over 50 Years of Age (2010-2015E)
Health Expenditures of China and Brazil (2008-2014)
Global Obese Population (2009-2014)
Global Healthcare Spending (2007-2014)
DCB use by Application Method (2015)
Treatment Mix for ISR Lesions (2014/2015)
Percentage of PAD device Usage hurt by DCBs (2015)
Global PAD Top Companies Revenue Comparison (2015)
Global PAD Top Companies CAGR Comparison (2011-2015)
Global Peripheral Atherectomy Market by Company (2015E)
The US Peripheral Atherectomy Market (2015)
CSII Revenue and Net Income (2011-2015*)
Medtronic’s Market Share by Business Unit (2015*)
MDT Revenue and Net Income (2011-2015*)
SPNC’s Revenue Share by Segment (2015)
SPNC Revenue and Net Income (2011-2015)
BSX Sales by Product Category (2014)
BSX Revenue and Net Income (2011-2015)
Global Peripheral Artery Disease Market Forecast (2014-2018F)

List of Tables

Factors Causing Peripheral Artery Disease
CSII’s FDA Approved Peripheral Artery Disease Systems
Spectranetics Product by Segment
Dependent & Independent Variables (2010– 2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output